| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |